Columbia Laboratories genitourinary news

Columbia hired Cowen and Co. LLC as a financial advisor to evaluate strategic transactions. In its 4Q11 earnings release on March 8, the company said it will evaluate "potential strategic transactions that will add value for our stockholders." Earlier this month, Columbia reduced headcount by 10 (42%) to 14 to save cash. At Dec. 31, 2011, the company had $25.1 million in cash a 12-month operating gain of $22.9 million (see BioCentury, March 5). ...